The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

The advent of biological therapy has revolutionized inflammatory bowel disease (IBD) care. Nonetheless, not all patients require biological therapy. Selection of patients depends on clinical characteristics, previous response to other medical therapy, and comorbid conditions. Availability, reimburse...

Full description

Bibliographic Details
Main Authors: D'Haens, G, Panaccione, R, Higgins, P, Vermeire, S, Gassull, M, Chowers, Y, Hanauer, S, Herfarth, H, Hommes, D, Kamm, M, Löfberg, R, Quary, A, Sands, B, Sood, A, Watermeyer, G, Watermayer, G, Lashner, B, Lémann, M, Plevy, S, Reinisch, W, Schreiber, S, Siegel, C, Targan, S, Watanabe, M, Feagan, B
Format: Journal article
Language:English
Published: 2011

Similar Items